1887

Abstract

Equine herpesvirus-1 (EHV-1) causes serious disease in horses throughout the world, despite the frequent use of vaccines. CTLs are thought to be critical for protection from primary and reactivating latent EHV-1 infections. However, the antigen-specificity of EHV-1-specific CTLs is unknown. The aim of this study was to identify EHV-1 genes that encode proteins containing CTL epitopes and to determine their MHC I (or ELA-A in the horse) restriction. Equine dendritic cells, transfected with a series of EHV-1 genes, were used to stimulate autologous CTL precursor populations derived from previously infected horses. Cytotoxicity was subsequently measured against EHV-1-infected PWM lymphoblast targets. Dendritic cells were infected with EHV-1 (positive control) or transfected with plasmids encoding the gB, gC, gD, gE, gH, gI, gL, immediate-early (IE) or early protein of EHV-1 using the PowderJect XR-1 research device. Dendritic cells transfected with the IE gene induced CTL responses in four of six ponies. All four of these ponies shared a common ELA-A3.1 haplotype. Dendritic cells transfected with gC, gD, gI and gL glycoproteins induced CTLs in individual ponies. The cytotoxic activity was ELA-A-restricted, as heterologous targets from ELA-A mismatched ponies were not killed and an MHC I blocking antibody reduced EHV-1-specific killing. This is the first identification of an EHV-1 protein containing ELA-A-restricted CTL epitopes. This assay can now be used to study CTL specificity for EHV-1 proteins in horses with a broad range of ELA-A haplotypes, with the goal of developing a multi-epitope EHV-1 vaccine.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19268-0
2003-10-01
2019-10-16
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/10/vir842625.html?itemId=/content/journal/jgv/10.1099/vir.0.19268-0&mimeType=html&fmt=ahah

References

  1. Allen, G. P. & Yeargan, M. R. ( 1987; ). Use of lambda gt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1. J Virol 61, 2454–2461.
    [Google Scholar]
  2. Allen, G. P., Yeargan, M., Costa, L. R. & Cross, R. ( 1995; ). Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J Virol 69, 606–612.
    [Google Scholar]
  3. Allen, G. P., Kydd, J. H., Slater, J. D. & Smith, K. C. ( 1999; ). Advances in understanding of the pathogenesis, epidemiology, and immunological control of equid herpesvirus abortion. In Equine Infectious Diseases VIII. Proceedings of the Eighth International Conference, Dubai, 23–26 March, 1998, 1st edn, pp. 129–146. Edited by U. Wernery, J. F. Wade, J. A. Mumford & O.-R. Kaaden. Newmarket: R & W Publications.
  4. Allen, T. M., Vogel, T. U., Fuller, D. H. & 11 other authors ( 2000; ). Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen. J Immunol 164, 4968–4978.[CrossRef]
    [Google Scholar]
  5. Antczak, D. F. ( 1992; ). The major histocompatibility complex of the horse. In Equine Infectious Diseases IV. Proceedings of the Sixth International Conference, Cambridge 1991, pp. 99–112. Edited by W. Plowright, P. D. Rossdale & J. F. Wade. Newmarket: R & W Publications.
  6. Antczak, D. F., Bailey, E., Barger, B. & 7 other authors ( 1986; ). Joint report of the Third International Workshop on Lymphocyte Alloantigens of the Horse, Kennett Square, Pennsylvania, 25–27 April 1984. Anim Genet 17, 363–373.
    [Google Scholar]
  7. Audibert, F. M. & Lise, L. D. ( 1993; ). Adjuvants: current status, clinical perspectives and future prospects. Trends Pharmacol Sci 14, 174–178.[CrossRef]
    [Google Scholar]
  8. Audonnet, J. C., Winslow, J., Allen, G. & Paoletti, E. ( 1990; ). Equine herpesvirus type 1 unique short fragment encodes glycoproteins with homology to herpes simplex virus type 1 gD, gI and gE. J Gen Virol 71, 2969–2978.[CrossRef]
    [Google Scholar]
  9. Bailey, E., Antczak, D. F., Bernoco, D. & 7 other authors ( 1984; ). Joint report of the Second International Workshop on Lymphocyte Alloantigens of the Horse, held 3–8 October 1982. Anim Blood Groups Biochem Genet 15, 123–132.
    [Google Scholar]
  10. Bailey, E., Marti, E., Fraser, D. G., Antczak, D. F. & Lazary, S. ( 2000; ). Immunogenetics of the horse. In The Genetics of the Horse, pp. 123–155. Edited by A. T. Bowling & A. Ruvinsky. New York: CABI.
  11. Banchereau, J. & Steinman, R. M. ( 1998; ). Dendritic cells and the control of immunity. Nature 392, 245–252.[CrossRef]
    [Google Scholar]
  12. Baxi, M. K., Efstathiou, S., Lawrence, G., Whalley, J. M., Slater, J. D. & Field, H. J. ( 1995; ). The detection of latency-associated transcripts of equine herpesvirus 1 in ganglionic neurons. J Gen Virol 76, 3113–3118.[CrossRef]
    [Google Scholar]
  13. Bhardwaj, N., Bender, A., Gonzalez, N., Bui, L. K., Garrett, M. C. & Steinman, R. M. ( 1995; ). Stimulation of human anti-viral CD8+ cytolytic T lymphocytes by dendritic cells. Adv Exp Med Biol 378, 375–379.
    [Google Scholar]
  14. Birch-Machin, I., Ryder, S., Taylor, L. & 11 other authors ( 2000; ). Utilisation of bacteriophage display libraries to identify peptide sequences recognised by equine herpesvirus type 1 specific equine sera. J Virol Methods 88, 89–104.[CrossRef]
    [Google Scholar]
  15. Borchers, K. & Slater, J. ( 1993; ). A nested PCR for the detection and differentiation of EHV-1 and EHV-4. J Virol Methods 45, 331–336.[CrossRef]
    [Google Scholar]
  16. Bryans, J. T. & Allen, G. P. ( 1989; ). Herpesviral diseases of the horse. In Herpesvirus Diseases of Cattle, Horses, and Pigs, pp. 176–229. Edited by G. Wittmann. Boston: Kluwer.
  17. Burki, F., Rossmanith, W., Nowotny, N., Pallan, C., Mostl, K. & Lussy, H. ( 1990; ). Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. Vet Q 12, 80–86.[CrossRef]
    [Google Scholar]
  18. Caughman, G. B., Lewis, J. B., Smith, R. H., Harty, R. N. & O'Callaghan, D. J. ( 1995; ). Detection and intracellular localization of equine herpesvirus 1 IR1 and IR2 gene products by using monoclonal antibodies. J Virol 69, 3024–3032.
    [Google Scholar]
  19. Chesters, P. M., Allsop, R., Purewal, A. & Edington, N. ( 1997; ). Detection of latency-associated transcripts of equid herpesvirus 1 in equine leukocytes but not in trigeminal ganglia. J Virol 71, 3437–3443.
    [Google Scholar]
  20. Cohen, J. ( 1993; ). Naked DNA points way to vaccines. Science 259, 1691–1692.[CrossRef]
    [Google Scholar]
  21. Crabb, B. S., Allen, G. P. & Studdert, M. J. ( 1991; ). Characterization of the major glycoproteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3 using monoclonal antibodies. J Gen Virol 72, 2075–2082.[CrossRef]
    [Google Scholar]
  22. Dohmann, K., Wagner, B., Horohov, D. W. & Leibold, W. ( 2000; ). Expression and characterisation of equine interleukin 2 and interleukin 4. Vet Immunol Immunopathol 77, 243–256.[CrossRef]
    [Google Scholar]
  23. Edington, N., Welch, H. M. & Griffiths, L. ( 1994; ). The prevalence of latent equid herpesviruses in the tissues of 40 abattoir horses. Equine Vet J 26, 140–142.[CrossRef]
    [Google Scholar]
  24. Ellis, R. W. ( 1999; ). New technologies for making vaccines. In Vaccines, 3rd edn, pp. 881–901. Edited by S. A. Plotkin & W. A. Orenstein. Philadelphia: W. B. Saunders.
  25. Ellis, J. A., Bogdan, J. R., Kanara, E. W., Morley, P. S. & Haines, D. M. ( 1995; ). Cellular and antibody responses to equine herpesviruses 1 and 4 following vaccination of horses with modified-live and inactivated viruses [see comments]. J Am Vet Med Assoc 206, 823–832.
    [Google Scholar]
  26. Elton, D. M., Bonass, W. A., Killington, R. A., Meredith, D. M. & Halliburton, I. W. ( 1991; ). Location of open reading frames coding for equine herpesvirus type-1 glycoproteins with homology to gE and gI of herpes simplex virus. Am J Vet Res 52, 1252–1257.
    [Google Scholar]
  27. Flowers, C. C., Flowers, S. P., Sheng, Y., Tarbet, E. B., Jennings, S. R. & O'Callaghan, D. J. ( 1995; ). Expression of membrane-bound and secreted forms of equine herpesvirus 1 glycoprotein D by recombinant baculovirus. Virus Res 35, 17–34.[CrossRef]
    [Google Scholar]
  28. Foster, C. S., Tsai, Y., Monroe, J. G., Campbell, R., Cestari, M., Wetzig, R., Knipe, D. & Greene, M. I. ( 1986; ). Genetic studies on murine susceptibility to herpes simplex keratitis. Clin Immunol Immunopathol 40, 313–325.[CrossRef]
    [Google Scholar]
  29. Fu, T. M., Bonneau, R. H., Epler, M., Tevethia, M. J., Alam, S., Verner, K. & Tevethia, S. S. ( 1996; ). Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein. Virology 222, 269–274.[CrossRef]
    [Google Scholar]
  30. Fu, T. M., Guan, L., Friedman, A., Schofield, T. L., Ulmer, J. B., Liu, M. A. & Donnelly, J. J. ( 1999; ). Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. J Immunol 162, 4163–4170.
    [Google Scholar]
  31. Gallichan, W. S., Johnson, D. C., Graham, F. L. & Rosenthal, K. L. ( 1993; ). Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J Infect Dis 168, 622–629.[CrossRef]
    [Google Scholar]
  32. Gilkerson, J. R., Love, D. N. & Whalley, J. M. ( 1998; ). Epidemiology of equine herpesvirus abortion: searching for clues to the future. Aust Vet J 76, 675–676.[CrossRef]
    [Google Scholar]
  33. Goldsby, R., Kindt, T. & Osborne, B. ( 2000; ). Kuby Immunology, 4th edn, pp. 427–429. New York: W. H. Freeman.
  34. Hammond, S. A., Horohov, D. & Montelaro, R. C. ( 1999; ). Functional characterization of equine dendritic cells propagated ex vivo using recombinant human GM-CSF and recombinant equine IL-4. Vet Immunol Immunopathol 71, 197–214.[CrossRef]
    [Google Scholar]
  35. Hassett, D. E. & Whitton, J. L. ( 1996; ). DNA immunization. Trends Microbiol 8, 307–312.
    [Google Scholar]
  36. Jones, C. M., Cose, S. C. & Carbone, F. R. ( 1997; ). Evidence for cooperation between TCR V region and junctional sequences in determining a dominant cytotoxic T lymphocyte response to herpes simplex virus glycoprotein B. Int Immunol 9, 1319–1328.[CrossRef]
    [Google Scholar]
  37. Koen, M. T., Walker, C., Wellington, J. E., Love, D. N. & Whalley, J. M. ( 2000; ). Characterisation of IE and UL5 gene products of equine herpesvirus 1 using DNA inoculation of mice. Arch Virol 145, 2677–2686.[CrossRef]
    [Google Scholar]
  38. Krisky, D. M., Wolfe, D., Goins, W. F., Marconi, P. C., Ramakrishnan, R., Mata, M., Rouse, R. J., Fink, D. J. & Glorioso, J. C. ( 1998; ). Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther 5, 1593–1603.[CrossRef]
    [Google Scholar]
  39. Kukreja, A., Love, D. N., Whalley, J. M. & Field, H. J. ( 1998; ). Study of the protective immunity of co-expressed glycoprotein H and L of equine herpesvirus-1 in a murine intranasal infection model. Vet Microbiol 60, 1–11.[CrossRef]
    [Google Scholar]
  40. Lekstrom-Himes, J. A., Hohman, P., Warren, T., Wald, A., Nam, J. M., Simonis, T., Corey, L. & Straus, S. E. ( 1999; ). Association of major histocompatibility complex determinants with the development of symptomatic and asymptomatic genital herpes simplex virus type 2 infections. J Infect Dis 179, 1077–1085.[CrossRef]
    [Google Scholar]
  41. Ludewig, B., Ehl, S., Karrer, U., Odermatt, B., Hengartner, H. & Zinkernagel, R. M. ( 1998; ). Dendritic cells efficiently induce protective antiviral immunity. J Virol 72, 3812–3818.
    [Google Scholar]
  42. Lunn, D. P., Holmes, M. A. & Antczak, D. F. ( 1996; ). Summary report of the 2nd Equine Leucocyte Antigen Worksop, July 1995, Squaw Valley, California. Vet Immunol Immunopathol 54, 159–161.[CrossRef]
    [Google Scholar]
  43. Lunn, D. P., Soboll, G., Schram, B. R. & 7 other authors ( 1999; ). Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine 17, 2245–2258.[CrossRef]
    [Google Scholar]
  44. McGuire, T. C., Zhang, W., Hines, M. T., Henney, P. J. & Byrne, K. M. ( 1997; ). Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses. Virology 238, 85–93.[CrossRef]
    [Google Scholar]
  45. McGuire, T. C., Leib, S. R., Lonning, S. M., Zhang, W., Byrne, K. M. & Mealey, R. H. ( 2000; ). Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses. J Gen Virol 81, 2735–2739.
    [Google Scholar]
  46. Manickan, E., Kanangat, S., Rouse, R. J., Yu, Z. & Rouse, B. T. ( 1997; ). Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J Leukoc Biol 61, 125–132.
    [Google Scholar]
  47. Munro, K. I., Wellington, J. E., Love, D. N. & Whalley, J. M. ( 1999; ). Characteristics of glycoprotein B of equine herpesvirus 1 expressed by a recombinant baculovirus. Vet Microbiol 68, 49–57.[CrossRef]
    [Google Scholar]
  48. Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D., Zajac, A. & Ahmed, R. ( 1998; ). In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection. Adv Exp Med Biol 452, 123–142.
    [Google Scholar]
  49. Nugent, C. T., McNally, J. M., Chervenak, R., Wolcott, R. M. & Jennings, S. R. ( 1995; ). Differences in the recognition of CTL epitopes during primary and secondary responses to herpes simplex virus infection in vivo. Cell Immunol 165, 55–64.[CrossRef]
    [Google Scholar]
  50. O'Brien, M. A., Holmes, M. A., Lunn, D. P. & Duffus, W. P. H. ( 1991; ). Evidence for MHC class-I restricted cytotoxicity in the one-way, primary mixed lymphocyte reaction. Equine Vet J Suppl. 12, 30–35.
    [Google Scholar]
  51. Oehen, S., Hengartner, H. & Zinkernagel, R. M. ( 1991; ). Vaccination for disease. Science 251, 195–198.[CrossRef]
    [Google Scholar]
  52. O'Neill, T., Kydd, J. H., Allen, G. P., Wattrang, E., Mumford, J. A. & Hannant, D. ( 1999; ). Determination of equid herpesvirus 1-specific, CD8+ cytotoxic T lymphocyte precursor frequencies in ponies. Vet Immunol Immunopathol 70, 43–54.[CrossRef]
    [Google Scholar]
  53. Osterrieder, N., Wagner, R., Brandmuller, C., Schmidt, P., Wolf, H. & Kaaden, O. R. ( 1995; ). Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology 208, 500–510.[CrossRef]
    [Google Scholar]
  54. Pedersen, L. G., Castelruiz, Y., Jacobsen, S. & Aasted, B. ( 2002; ). Identification of monoclonal antibodies that cross-react with cytokines from different animal species. Vet Immunol Immunopathol 88, 111–122.[CrossRef]
    [Google Scholar]
  55. Ramsay, A. J., Kent, S. J., Strugnell, R. A., Suhrbier, A., Thomson, S. A. & Ramshaw, I. A. ( 1999; ). Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity. Immunol Rev 171, 27–44.[CrossRef]
    [Google Scholar]
  56. Ridgely, S. L. & McGuire, T. C. ( 2002; ). Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horses. Vaccine 20, 1809–1819.[CrossRef]
    [Google Scholar]
  57. Rouse, R. J., Nair, S. K., Lydy, S. L., Bowen, J. C. & Rouse, B. T. ( 1994; ). Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins. J Virol 68, 5685–5689.
    [Google Scholar]
  58. Ruitenberg, K. M., Walker, C., Wellington, J. E., Love, D. N. & Whalley, J. M. ( 1999a; ). DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection. Vaccine 17, 237–244.[CrossRef]
    [Google Scholar]
  59. Ruitenberg, K. M., Walker, C., Wellington, J. E., Love, D. N. & Whalley, J. M. ( 1999b; ). Potential of DNA-mediated vaccination for equine herpesvirus 1. Vet Microbiol 68, 35–48.[CrossRef]
    [Google Scholar]
  60. Ruitenberg, K. M., Love, D. N., Gilkerson, J. R., Wellington, J. E. & Whalley, J. M. ( 2000a; ). Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody. Vet Microbiol 76, 117–127.[CrossRef]
    [Google Scholar]
  61. Ruitenberg, K. M., Walker, C., Love, D. N., Wellington, J. E. & Whalley, J. M. ( 2000b; ). A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naive and infection-primed mice. Vaccine 18, 1367–1373.[CrossRef]
    [Google Scholar]
  62. Siedek, E. M., Whelan, M., Edington, N. & Hamblin, A. ( 1999; ). Equine herpesvirus type 1 infects dendritic cells in vitro: stimulation of T lymphocyte proliferation and cytotoxicity by infected dendritic cells. Vet Immunol Immunopathol 67, 17–32.[CrossRef]
    [Google Scholar]
  63. Simmons, A. ( 1989; ). H-2-linked genes influence the severity of herpes simplex virus infection of the peripheral nervous system. J Exp Med 169, 1503–1507.[CrossRef]
    [Google Scholar]
  64. Smith, R. H., Holden, V. R. & O'Callaghan, D. J. ( 1995; ). Nuclear localization and transcriptional activation activities of truncated versions of the immediate-early gene product of equine herpesvirus 1. J Virol 69, 3857–3862.
    [Google Scholar]
  65. Smith, P. M., Zhang, Y., Jennings, S. R. & O'Callaghan, D. J. ( 1998; ). Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice. J Virol 72, 5366–5372.
    [Google Scholar]
  66. Soboll, G., Nelson, K. M., Leuthner, E. S., Clark, R. J., Drape, R., Macklin, M., Swain, W. F. & Lunn, D. P. ( 2003; ). Mucosal co-administration of cholera toxin and influenza virus hemagglutinin DNA in ponies generates a local IgA response. Vaccine 21, 3081–3092.[CrossRef]
    [Google Scholar]
  67. Sohn, S., Lee, E. S. & Lee, S. ( 2001; ). The correlation of MHC haplotype and development of Behcet's disease-like symptoms induced by herpes simplex virus in several inbred mouse strains. J Dermatol Sci 26, 173–181.[CrossRef]
    [Google Scholar]
  68. Steinbach, F., Borchers, K., Ricciardi-Castagnoli, P., Ludwig, H., Stingl, G. & Elbe-Burger, A. ( 1998; ). Dendritic cells presenting equine herpesvirus-1 antigens induce protective anti-viral immunity. J Gen Virol 79, 3005–3014.
    [Google Scholar]
  69. Stokes, A., Alber, D. G., Cameron, R. S., Marshall, R. N., Allen, G. P. & Killington, R. A. ( 1996; ). The production of a truncated form of baculovirus expressed EHV-1 glycoprotein C and its role in protection of C3H (H-2Kk) mice against virus challenge. Virus Res 44, 97–109.[CrossRef]
    [Google Scholar]
  70. Tewari, D., Whalley, J. M., Love, D. N. & Field, H. J. ( 1994; ). Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. J Gen Virol 75, 1735–1741.[CrossRef]
    [Google Scholar]
  71. Walker, C., Ruitenberg, K., Wellington, J., Whalley, J. M. & Love, D. N. ( 1997; ). Genetic immunization with equine herpesvirus-1 glycoprotein D. First International Veterinary Vaccines and Diagnostics Conference, Madison, Wisconsin, July 1997, p. 93.
  72. Wellington, J. E., Lawrence, G. L., Love, D. N. & Whalley, J. M. ( 1996a; ). Expression and characterization of equine herpesvirus 1 glycoprotein D in mammalian cell lines. Arch Virol 141, 1785–1793.[CrossRef]
    [Google Scholar]
  73. Wellington, J. E., Love, D. N. & Whalley, J. M. ( 1996b; ). Evidence for involvement of equine herpesvirus 1 glycoprotein B in cell–cell fusion. Arch Virol 141, 167–175.[CrossRef]
    [Google Scholar]
  74. Whalley, J. M., Love, D. N., Tewari, D. & Field, H. J. ( 1995; ). Characteristics of equine herpesvirus 1 glycoproteins expressed in insect cells. Vet Microbiol 46, 193–201.[CrossRef]
    [Google Scholar]
  75. Zhang, W., Lonning, S. M. & McGuire, T. C. ( 1998; ). Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection. J Virol 72, 9612–9620.
    [Google Scholar]
  76. Zhao, Y., Holden, V. R., Smith, R. H. & O'Callaghan, D. J. ( 1995; ). Regulatory function of the equine herpesvirus 1 ICP27 gene product. J Virol 69, 2786–2793.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19268-0
Loading
/content/journal/jgv/10.1099/vir.0.19268-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error